Is an extended dose of subcutaneous nadroparin anticoagulation equally safe and feasible compared to unfractionated heparin anticoagulation during extracorporeal membrane oxygenation in critically ill COVID-19 patients?

Introduction Unfractionated heparin (UFH) is the traditional anticoagulant of choice in critically ill COVID-19 patients requiring extracorporeal membrane oxygenation (ECMO). Nadroparin, a low molecular weight heparin, potentially offers advantages such as predictable pharmacokinetics and reduced bl...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Paweł Piwowarczyk, Marta Szczukocka, Agata Uchacz, Paweł Kutnik, Tomasz Czarnik, Mirosław Czuczwar, Michał Borys
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Termedia Publishing House 2025-04-01
Seri Bilgileri:	Anaesthesiology Intensive Therapy
Konular:	respiratory heparin anticoagulation ecmo oxygenation extracorporeal covid-19 nadroparin extended unfractionated
Online Erişim:	https://www.ait-journal.com/Is-an-extended-dose-of-subcutaneous-nadroparin-anticoagulation-equally-safe-and-feasible,202605,0,2.html
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!